Morgan Stanley analyst Matthew Sharpe downgrades Science Applications Intl (NYSE:SAIC) from Overweight to Equal-Weight and raises the price target from $108 to $114.
Evercore ISI Group analyst Elizabeth Anderson downgrades Health Catalyst (NASDAQ:HCAT) from Outperform to In-Line and raises the price target from $10 to $11.